Related Experiment Video
Updated: Jul 3, 2026
08:16
Generating Human Pancreatic Tissue Slices to Study Endocrine and Exocrine Pancreas Physiology
Published on: March 15, 2024
The changing shape of type 2 diabetes.
1Stamford Hospital, Columbia University, Charlotte, North Carolina; Cabarrus Family Medicine Residency Program, Concord, North Carolina, USA.
Medscape Journal of Medicine
|August 6, 2008
Summary
Effective type 2 diabetes management requires lifestyle changes and medication. Intensive glycemic control, including insulin therapy when needed, is crucial for preventing long-term microvascular and macrovascular complications.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Type 2 diabetes (T2D) traditionally affects older adults but is increasingly prevalent in younger populations due to lifestyle factors like obesity.
- This demographic shift necessitates a review of current T2D treatment guidelines.
- Emerging treatments include insulin analogs and incretin-targeting drugs.
Purpose of the Study:
- To review current treatment strategies for type 2 diabetes.
- To emphasize the importance of glycemic control in managing diabetes-related complications.
Main Methods:
- A literature review was conducted using PubMed.
- Search terms relevant to type 2 diabetes treatment were utilized.
- The search was performed in August 2007.
Main Results:
- Lifestyle interventions (diet, physical activity) are foundational but challenging for many patients.
- Metformin is recommended alongside lifestyle changes upon diagnosis.
- A stepwise approach adding oral antidiabetic drugs (OADs) is advised as T2D progresses.
- Insulin therapy is indicated when OADs fail to achieve glycemic targets.
- Intensive glycemic control demonstrably reduces microvascular complications and may benefit macrovascular outcomes.
Conclusions:
- Maintaining optimal glycemic control is paramount for patients with type 2 diabetes.
- Treatment regimens must be adapted to individual patient needs and glycemic goals.
- Effective, long-term glycemic management is key to minimizing both microvascular and macrovascular comorbidities associated with diabetes.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...